Download FREE Report Sample
Download Free sampleContinuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
Continuous Subcutaneous Insulin Infusion Devices Market contains market size and forecasts of Continuous Subcutaneous Insulin Infusion Devices in global, including the following market information:
Global Continuous Subcutaneous Insulin Infusion Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Continuous Subcutaneous Insulin Infusion Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Continuous Subcutaneous Insulin Infusion Devices companies in 2021 (%)
The global Continuous Subcutaneous Insulin Infusion Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Normal Pump Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Continuous Subcutaneous Insulin Infusion Devices include Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL and Microport, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Continuous Subcutaneous Insulin Infusion Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Subcutaneous Insulin Infusion Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Subcutaneous Insulin Infusion Devices Market Segment Percentages, by Type, 2021 (%)
Normal Pump
Patch Pump
Global Continuous Subcutaneous Insulin Infusion Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Subcutaneous Insulin Infusion Devices Market Segment Percentages, by Application, 2021 (%)
Type I Diabetes
Type II Diabetes
Global Continuous Subcutaneous Insulin Infusion Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Subcutaneous Insulin Infusion Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Subcutaneous Insulin Infusion Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Continuous Subcutaneous Insulin Infusion Devices revenues share in global market, 2021 (%)
Key companies Continuous Subcutaneous Insulin Infusion Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Continuous Subcutaneous Insulin Infusion Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Roche
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL
Microport
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
